Tesamorelin–Quick detial :
- Tesamorelin 2mg/vial
Tesamorelin (also known as Egrifta) is a synthetic form of -releasing hormone which is used in the treatment of HIV-associated lipodystrophy.
Tesamorelin–Product name :Tesamorelin(2mg/Vial 10vial/Kit )
Tesamorelin–CAS: 218949-48-5 / 804475-66-9
Tesamorelin–Tesamorelin Purity (HPLC):≥98.00%
Tesamorelin–Appearance : White lyophilized powder
Usage :Triptorelin raises testosterone levels by causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction.
Tesamorelin is a synthetic peptide consisting of all 44 amino acids of hGRF with the addition of a trans-3-Hexenoic acid group.
Tesamorelin (also known as Egrifta) is a synthetic form of growth-hormone-releasing hormone which is used in the treatment of HIV-associated lipodystrophy.
Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals. Lipodystrophy is a condition that causes changes in placement of body fat, including wasting and fat accumulation, and changes in metabolism.
Similar to Tesamorelin is Sermorelin, which may be taken with GHRP-6 is clinical trials, that also promotes production and possible fat loss.